Gene · 2057
Papers3,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,982
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| JAK2 Unmutated Erythrocytosis: 2026 Update on Diagnosis and Management. | Am J Hematol | 2025 | 41123216 | PubTator, text mining | PubMed |
| A meta-analysis of diagnostic challenges in Ph-like ALL at baseline: early detection strategies for personalized therapeutic interventions. | Int J Hematol | 2025 | 41107633 | PubTator, text mining | PubMed |
| Pegmolesatide ameliorates indoxyl sulfate-induced cardiomyocyte hypertrophy through modulating the EPOR-CD131-dependent JAK2/STAT3 signaling pathway. | Int Immunopharmacol | 2025 | 41092772 | PubTator, text mining | PubMed |
| Treatment of EPOR-rearranged acute lymphoblastic leukemia with ruxolitinib: case reports and review of the literature. | Ann Hematol | 2025 | 41020996 | PubTator, text mining | PubMed |
| AdaSemb: an adaptive knowledge-driven deep learning framework integrating cancer protein assemblies for predicting PI3Kα inhibitor response and resistance. | Brief Bioinform | 2025 | 41020523 | PubTator, text mining | PubMed |
| PACLseq: A Standalone Diagnostic Method for Ph-Like Acute Lymphoblastic Leukemia Using Nanopore Sequencing. | MedComm (2020) | 2025 | 40969300 | PubTator, text mining | PubMed |
| An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivo. | Protein Sci | 2025 | 40960423 | PubTator, text mining | PubMed |
| Transcriptional dynamics of the oligodendrocyte lineage and its regulation by the brain erythropoietin system. | Nat Commun | 2025 | 40957896 | PubTator, text mining | PubMed |
| Genetic Insight Into Dissecting the FODMAP Diet Frame and Liver Cancer: The Mediation Role of Efferocytosis and Trogocytosis. | Food Sci Nutr | 2025 | 40895144 | PubTator, text mining | PubMed |
| Genetic adaptations shaping survival, pregnancy, and life at high altitude and sea level. | Philos Trans R Soc Lond B Biol Sci | 2025 | 40836810 | PubTator, text mining | PubMed |
| An Overview of Neuroprotective Effects of Erythropoietin Against Neurological Disorders: Beyond Erythropoiesis. | J Biochem Mol Toxicol | 2025 | 40808348 | PubTator, text mining | PubMed |
| Multimodal profiling reveals tissue-directed signatures of human immune cells altered with age. | Nat Immunol | 2025 | 40804529 | PubTator, text mining | PubMed |
| Erythropoietin controls surface expression of its receptor via endoplasmic reticulum translocation. | Biochem Biophys Res Commun | 2025 | 40749614 | PubTator, text mining | PubMed |
| Method Development of Pegmolesatide for Doping Analysis: A Novel Synthetic Erythropoietin-Mimetic Agent. | Drug Test Anal | 2025 | 40675650 | PubTator, text mining | PubMed |
| iVAE: an interpretable representation learning framework enhances clustering performance for single-cell data. | BMC Biol | 2025 | 40660220 | PubTator, text mining | PubMed |
| A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia. | Clin Lymphoma Myeloma Leuk | 2025 | 40500616 | PubTator, text mining | PubMed |
| Correction: Overview of preclinical and phase II clinical studies on Pegmolesatide's long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction. | J Transl Med | 2025 | 40462122 | PubTator, text mining | PubMed |
| JAK-STAT Signaling in Autoimmunity and Cancer. | Immunotargets Ther | 2025 | 40376194 | PubTator, text mining | PubMed |
| Evidence of a hormetic-like cytoprotective effect by erythropoietin in the SH-SY5Y cell model of oxygen-glucose deprivation. | Neuroscience | 2025 | 40368234 | PubTator, text mining | PubMed |
| Regulation of Erythropoietin Activity in Clear Renal Cell Carcinoma. | Int J Mol Sci | 2025 | 40332447 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2057/papers?page=5